search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
50 new news items in the last 24 hours
  1. Home
  2. International

Eli Lilly will build a factory in Lehigh Valley, Pennsylvania, to produce treatments for obesity, including retatrutide, with an investment of 3.5 billion dollars.

Cristiana Dida
whatsapp
facebook
linkedin
x
copy-link copy-link
31 January 2026, 06:33
main event image
International
Foto: Facebook/ Eli Lilly and Company
google-preference

Always see our news on Google

Eli Lilly has announced an investment of over 3.5 billion dollars in a new factory in Lehigh Valley, Pennsylvania, which will produce innovative treatments for obesity, including the experimental drug retatrutide. This is the fourth facility in a series of investments that the company has launched in the U.S., part of a broader 27 billion dollar program for domestic production facilities, in addition to 23 billion invested since 2020.


Construction of the new factory will begin this year, and the unit is expected to become operational in 2031, creating approximately 850 direct jobs. Retatrutide is considered a key element of the company's long-term strategy, with the potential to help patients with severe obesity. Lilly and its rival, Novo Nordisk, are expanding their production capacities in the U.S. in response to past supply issues and pressures regarding tariffs on imported drugs.

Sources

sursa imagine
News.ro
Eli Lilly investeşte 3,5 miliarde de dolari într-o fabrică pentru medicamente anti-obezitate în Pennsylvania
sursa imagine
CBS News
Eli Lilly to build $3.5B plant in Pennsylvania's Lehigh Valley to produce weight-loss drugs
sursa imagine
independent.co.uk
Drugmaker Eli Lilly announces new plant in Pennsylvania as part of broader domestic expansion

Latest News

22:59

The Pentagon is asking the American defense industry to rapidly increase the production and delivery of weapons.

22:45

CNAS reveals fraud in the healthcare system: Fake consultations for vulnerable patients: "They forgot to ask if the patients are still alive"

22:38

A WHO medical supplies depot in Dnipro, Ukraine, was attacked and destroyed.

22:29

The police in Botoșani discovered a body buried in the yard of a house belonging to a man who went missing in April. His partner has been arrested for qualified murder.

22:05

Elon Musk refuses the use of Starlink by Ukraine for attacks in Russia

See more news

NEWS ON THE SAME TOPICS

event image
Economy
The Ukrainian manufacturer Biopharma is doubling its investment in Oradea, reaching 85 million euros for the first phase of the pharmaceutical factory.
event image
International
The European Medicines Agency has recommended the approval of the Wegovy tablet, a weight loss medication from Novo Nordisk.
event image
Health
Cats could benefit from weight loss medications. The first tests are already underway.
event image
Health
France will start partial reimbursement of treatments for obesity from June, thus becoming the first state in the EU to subsidize these medications.
event image
Current Affairs
Philip Morris International has invested over 1.1 billion dollars in Romania, mostly in the factory in Otopeni, converted for smoke-free products. Over 90% of production is intended for export.
event image
International
France will start reimbursing weight loss medications from June 15, becoming the first European country to cover these treatments.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
eli lilly investment factory Pennsylvania

Editor’s Recommendations

main event image
Current Affairs
Yesterday 17:58

Irinel Scrioșteanu, after the sinking of the barges in the Danube: A hard-fought battle, good result, but the danger has not passed [...] the currents of the Danube are strong and can be very unpredictable.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+5
main event image
Opinions
8 August 2026, 18:08

Andrei Cornea: "The many" and their detested experts

main event image
Exclusive
8 August 2026, 09:25
Original Content

IT News Review by Control F5 Software: EU considers it necessary to monitor high-risk AI systems

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol